Assignee
IMMUNESENSOR THERAPEUTICS INC
US·12 granted patents·8 pending applications·16 citations·filing 2018–2025
Top patents by PatentIndex Score
20 records- 0193US11033635B2Antibody-STING agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·3 cites·28 claims
- 0292US11873291B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·3 cites·52 claims
- 0390US10947206B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·3 cites·46 claims
- 0487US11597707B2CGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·1 cites·26 claims
- 0586US10519188B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·21 claims
- 0684US2025115564A1cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0782US2025115579A1QUINOLINE cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0880US12134609B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Nov 5, 2024·0 cites·23 claims
- 0980US12065416B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·0 cites·32 claims
- 1076US12091387B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 1175US12281078B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·0 cites·26 claims
- 1272US12311030B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted May 27, 2025·0 cites·17 claims
- 1371US11213592B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 4, 2022·0 cites·26 claims
- 1470US2022340613A1Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1569US2026042737A1QUINOLINE cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1659US11299512B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·0 cites·34 claims
- 1758US2026092048A1Solid forms and salts of a quinoline cgas antagonist compoundIMMUNESENSOR THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1857US2023121320A1Sting agonist combination treatments with cytokinesIMMUNESENSOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1957US2021380695A1Sting agonist combination treatments with immune checkpoint inhibitorsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2054US2023270773A1Methods of treating cancer with a sting agonistIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when IMMUNESENSOR THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →